N2 Biomedical, LLC — Department of Health and Human Services SBIR Phase I: NIDCR

N2 Biomedical, LLC — SBIR Phase I award from Department of Health and Human Services.

Amount
$224,999
Agency
Department of Health and Human Services · National Institutes of Health
Program / Phase
SBIR · Phase I
Topic
NIDCR
Solicitation
PA14-071
NAICS
Place of performance
MA
Period
2015-09-01 → 2016-08-31

Description

DESCRIPTION provided by applicant Peri implantitis is a disease characterized by progressive loss of bone surrounding dental implants which may occur many years after successful implantation In this program a dual mode surface treatment will be developed that will encourage a strong interface between the implant and living bone and gingival tissue while also providing a long lasting anti bacterial effect to discourage the bacterial precursors to peri implantitis To achieve this goal two complementary surface modifications will be applied A nano textured surface will be developed based on predictive modeling in which anti bacterial pro osteoblast and pro gingival fibroblast properties will be selected The textured coating material will be an amorphous silver doped titania deposited by ion beam assisted deposition This coating will bond aggressively to the Ti implant surface and itself provide significant and very long lasting antimicrobial efficacy Efficacy will be demonstrated through combination perio pathogenic bacteria osteoblast and gingival fibroblast cell assays This combination of morphologic and material approaches will promote osseointegration and a healthy mucosal seal while also providing very long lasting antimicrobial protection that will significantly reduc the occurrence of peri implantitis associated with dental implants PUBLIC HEALTH RELEVANCE Peri implantitis is a disease characterized by progressive loss of the bone surrounding dental implants which may occur many years after successful implantation In this program a dual mode surface treatment will be developed that will encourage a strong interface between the implant and living bone while also providing an extremely long lasting antimicrobial action to discourage the bacterial precursors of peri implantitis